GL1X · GenesisL1 explorer

MolNFT v1 · #115023 · protein

Fragment-based drug discovery targeting inhibitor of apoptosis proteins: compound 5

5C7B · E3 ubiquitin-protein ligase xiap: “Fragment-based drug discovery targeting inhibitor of apoptosis proteins: compound 5”. X-ray diffraction, 2 ligands (4YD, ZN). MolNFT v1 #115023 on GenesisL1: 3D structure, binding sites and pockets…

PDB
5C7B
Type
protein
Length
106 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
E3 ubiquitin-protein ligase xiap
EC
6.3.2.-
UniProt
P98170
Ligands
4YD, ZN

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AE3 ubiquitin-protein ligase xiap (EC 6.3.2.-)protein10642% helix, 8% strandP98170

Ligands and binding sites

  • 4YD · (2R)-2-methyl-4-[2-oxo-2-(pyrrolidin-1-yl)ethyl]piperazin-1-ium · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5C7B · Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 5 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.